Cover Image
市場調查報告書

成人惡性神經膠質瘤:全球臨床實驗檢討

Adult Malignant Glioma Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 296843
出版日期 內容資訊 英文 93 Pages
訂單完成後即時交付
價格
Back to Top
成人惡性神經膠質瘤:全球臨床實驗檢討 Adult Malignant Glioma Global Clinical Trials Review, H1, 2014
出版日期: 2014年02月26日 內容資訊: 英文 93 Pages
簡介

本報告提供成人惡性神經膠質瘤(Glioma)相關臨床研究的最新趨勢分析,以疾病概要為首,彙整主要國家的臨床實驗狀況,各地區、各階段的進行狀況,受驗者的募集情況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊,為您概述為以下內容。

目錄

簡介

  • 成人惡性神經膠質瘤(神經膠質瘤)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量

在G7各國臨床實驗數量:佔腫瘤整體比率

在G7各國臨床實驗數量:各階段

在G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

  • 參加成人惡性神經膠質瘤的治療藥臨床實驗的前幾名企業

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Insys Therapeutics, Inc.
    • Eli Lilly and Company
    • Sigma-Tau S.p.A.
    • Sanofi
    • Merck & Co., Inc.
    • GlaxoSmithKline plc
    • Amgen Inc.
  • 有代表性的醫院·研究機關臨床實驗概要
    • National Cancer Institute
    • Duke University
    • 信州大學
    • Istituti Fisioterapici Ospitalieri
    • 東北大學
    • Medical Research Council
    • 大阪大學
    • Memorial Sloan Kettering Cancer Center
    • Emory University

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2004CTIDB

GlobalData's clinical trial report, "Adult Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Adult Malignant Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Adult Malignant Glioma . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Adult Malignant Glioma . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Adult Malignant Glioma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Adult Malignant Glioma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Adult Malignant Glioma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Insys Therapeutics, Inc.
      • Clinical Trial Overview of Insys Therapeutics, Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Sigma-Tau S.p.A.
      • Clinical Trial Overview of Sigma-Tau S.p.A.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Duke University
      • Clinical Trial Overview of Duke University
      • Shinshu University
      • Clinical Trial Overview of Shinshu University
      • Istituti Fisioterapici Ospitalieri
      • Clinical Trial Overview of Istituti Fisioterapici Ospitalieri
      • Tohoku University
      • Clinical Trial Overview of Tohoku University
      • Medical Research Council
      • Clinical Trial Overview of Medical Research Council
      • Osaka University
      • Clinical Trial Overview of Osaka University
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Emory University
      • Clinical Trial Overview of Emory University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Adult Malignant Glioma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Adult Malignant Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Adult Malignant Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Adult Malignant Glioma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Adult Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Adult Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Adult Malignant Glioma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Adult Malignant Glioma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Adult Malignant Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Adult Malignant Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Insys Therapeutics, Inc., 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sigma-Tau S.p.A., 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shinshu University, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituti Fisioterapici Ospitalieri, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014*

List of Figures

  • Adult Malignant Glioma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Adult Malignant Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Adult Malignant Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Proportion of Adult Malignant Glioma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Adult Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Adult Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Adult Malignant Glioma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Adult Malignant Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Adult Malignant Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Adult Malignant Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top